Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1975 Apr 1;141(4):736–752.

Humoral immunostimulation. IV. Role of complement

PMCID: PMC2189750  PMID: 1168690

Abstract

When L cells were treated with anti-L-cell antibody in medium containing heat-inactivated fetal calf serum, nucleoside uptake and cell growth were stimulated. The response was markedly increased when fresh, unheated sera from calves, guinea pigs, humans, mice, or rabbits were also present. The factors in unheated serum responsible for the enhancement of immunostimulation were studied. Using low concentrations of sera deficient in various complement (C) components and low concentrations of antibody no augmentation of immunostimulation was seen with Clr-deficient human serum, C2-deficient human serum, C2,4- deficient human serum, C4-deficient guinea pig serum, C3-C9-depleted guinea pig serum (by administration of cobra venom factor to animals), but stimulation was observed with C5-deficient human serum, C5- deficient mouse serum, and C6-deficient rabbit serum. When the concentration of anti-serum was raised, however, augmentation was observed with C4-deficient guinea pig serum. Thus, at low concentrations of antiserum enhancement appeared to occur through the classical C pathway, whereas at high concentrations of antibody either the classical or alternate C pathways appeared to be involved. Stimulation was specifically restored by purified C2 in C2-deficient serum and by C3 in C3-C9-deficient serum. Under the usual reaction conditions consumption of guinea pig C component C4 could be demonstrated which provided direct evidence for activation of the classical C pathway under conditions leading to immunostimulation. By immunofluorescence, cells treated with antibody and normal human serum had human C3 deposited at the cell surface. Taken together these observations suggest that C activated through C3 by either the classical or alternate pathways has the potential to enhance nucleoside incorporation into DNA and cell growth of cells exposed to limiting amounts of antibody. Although the mechanism of stimulation is unknown, it is likely to involve a direct effect of C3 at the level of the cell membrane.

Full Text

The Full Text of this article is available as a PDF (1,000.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arend P., Malchow H., Cappeller D. Possibility of enzymatic interaction between polymorphonuclear leukocytes and autologous lymphocytes in the mitogen-induced lymphocyte proliferation. Z Immunitatsforsch Exp Klin Immunol. 1972 Dec;144(4):366–371. [PubMed] [Google Scholar]
  2. Atkinson J. P., Glew R. H., Neva F. A., Frank M. M. Serum complement and immunity in experimental simian malaria. II. Preferential activation of early components and failure of depletion of late components to inhibit protective immunity. J Infect Dis. 1975 Jan;131(1):26–33. doi: 10.1093/infdis/131.1.26. [DOI] [PubMed] [Google Scholar]
  3. Borsos T., Rapp H. J. Immune hemolysis: a simplified method for the preparation of EAC'4 with guinea pig or with human complement. J Immunol. 1967 Aug;99(2):263–268. [PubMed] [Google Scholar]
  4. Dukor P., Hartmann K. U. Hypothesis. Bound C3 as the second signal for B-cell activation. Cell Immunol. 1973 Jun;7(3):349–356. doi: 10.1016/0008-8749(73)90199-8. [DOI] [PubMed] [Google Scholar]
  5. Frank M. M., May J., Gaither T., Ellman L. In vitro studies of complement function in sera of C4-deficient guinea pigs. J Exp Med. 1971 Jul 1;134(1):176–187. doi: 10.1084/jem.134.1.176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gaither T. A., Alling D. W., Frank M. M. A new one-step method for the functional assay of the fourth component (C4) of human and guinea pig complement. J Immunol. 1974 Aug;113(2):574–583. [PubMed] [Google Scholar]
  7. Gigli I., Nelson R. A., Jr Complement dependent immune phagocytosis. I. Requirements for C'1, C'4, C'2, C'3. Exp Cell Res. 1968 Jul;51(1):45–67. doi: 10.1016/0014-4827(68)90158-4. [DOI] [PubMed] [Google Scholar]
  8. Goodkofsky I., Lepow I. H. Functional relationship of factor B in the properdin system to C3 proactivator of human serum. J Immunol. 1971 Oct;107(4):1200–1204. [PubMed] [Google Scholar]
  9. Güttler F. Phospholipid synthesis in HeLa cells exposed to immunoglobulin G and complement. Biochem J. 1972 Jul;128(4):953–960. doi: 10.1042/bj1280953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kane M. A., May J. E., Frank M. M. Interactions of the classical and alternate complement pathway with endotoxin lipopolysaccharide. Effect on platelets and blood coagulation. J Clin Invest. 1973 Feb;52(2):370–376. doi: 10.1172/JCI107193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lepow I. H., Willms-Kretschmer K., Patrick R. A., Rosen F. S. Gross and ultrastructural observations on lesions produced by intradermal injection of human C3a in man. Am J Pathol. 1970 Oct;61(1):13–23. [PMC free article] [PubMed] [Google Scholar]
  12. May J. E., Frank M. M. A new complement-mediated cytolytic mechanism--the C1-bypass activation pathway. Proc Natl Acad Sci U S A. 1973 Mar;70(3):649–652. doi: 10.1073/pnas.70.3.649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mazzei D., Novi C., Bazzi C. Mitogenic action of trypsin and chymotrypsin. Lancet. 1966 Jul 23;2(7456):232–232. doi: 10.1016/s0140-6736(66)92526-8. [DOI] [PubMed] [Google Scholar]
  14. NILSSON U. R., MUELLER-EBERHARD H. J. ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT. J Exp Med. 1965 Aug 1;122:277–298. doi: 10.1084/jem.122.2.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Nelson R. A., Jr, Jensen J., Gigli I., Tamura N. Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum. Immunochemistry. 1966 Mar;3(2):111–135. doi: 10.1016/0019-2791(66)90292-8. [DOI] [PubMed] [Google Scholar]
  16. Neva F. A., Howard W. A., Glew R. H., Krotoski W. A., Gam A. A., Collins W. E., Atkinson J. P., Frank M. M. Relationship of serum complement levels to events of the malarial paroxysm. J Clin Invest. 1974 Aug;54(2):451–460. doi: 10.1172/JCI107781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pickering R. J., Naff G. B., Stroud R. M., Good R. A., Gewurz H. Deficiency of C1r in human serum. Effects on the structure and function of macromolecular C1. J Exp Med. 1970 Apr 1;131(4):803–815. doi: 10.1084/jem.131.4.803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Raisz L. G., Sandberg A. L., Goodson J. M., Simmons H. A., Mergenhagen S. E. Complement-dependent stimulation of prostaglandin synthesis and bone resorption. Science. 1974 Aug 30;185(4153):789–791. doi: 10.1126/science.185.4153.789. [DOI] [PubMed] [Google Scholar]
  19. Rother K., Rother U., Müller-Eberhard H. J., Nilsson J. R. Deficiency of the sixth component of complement in rabbits with an inherited complement defect. J Exp Med. 1966 Oct 1;124(4):773–785. doi: 10.1084/jem.124.4.773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ruddy S., Gigli I., Austen K. F. The complement system of man. I. N Engl J Med. 1972 Sep 7;287(10):489–495. doi: 10.1056/NEJM197209072871005. [DOI] [PubMed] [Google Scholar]
  21. Saito M., Yoshizawa T., Aoyagi T., Nagai Y. Involvement of proteolytic acivity in early events in lymphocyte transformation by phytohemagglutinin. Biochem Biophys Res Commun. 1973 May 15;52(2):569–575. doi: 10.1016/0006-291x(73)90750-x. [DOI] [PubMed] [Google Scholar]
  22. Shearer W. T., Philpott G. W., Parker C. W. Humoral immunostimulation. I. Increased uptake of (125I)iododeoxyuridine and (3H)thymidine into TNP-cells treated with anti-TNP antibody. J Exp Med. 1974 Feb 1;139(2):367–379. doi: 10.1084/jem.139.2.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Shearer W. T., Philpott G. W., Parker C. W. Stimulation of cells by antibody. Science. 1973 Dec 28;182(4119):1357–1359. doi: 10.1126/science.182.4119.1357. [DOI] [PubMed] [Google Scholar]
  24. Tchórzewski H., Sulowska Z., Denys A. A new lymphocyte transforming factor derived from the lysosomes of polymorphonuclear leucocytes. Experientia. 1973 Apr 15;29(4):481–483. doi: 10.1007/BF01926795. [DOI] [PubMed] [Google Scholar]
  25. Theofilopoulos A. N., Bokisch V. A., Dixon F. J. Receptor for soluble C3 and C3b on human lymphoblastoid (RAJI) cells. Properties and biologocal significance. J Exp Med. 1974 Mar 1;139(3):696–711. doi: 10.1084/jem.139.3.696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Unkeless J. C., Tobia A., Ossowski L., Quigley J. P., Rifkin D. B., Reich E. An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses. J Exp Med. 1973 Jan 1;137(1):85–111. doi: 10.1084/jem.137.1.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Weis L. S., Narahara H. T. Regulation of cell membrane permeability in skeletal muscle. I. Action of insulin and trypsin on the transport system for sugar. J Biol Chem. 1969 Jun 10;244(11):3084–3091. [PubMed] [Google Scholar]
  28. Yang T. J., Vas S. I. Effects of antibodies on L5178Y mouse leukemia cells cultured in vitro. Cancer Res. 1970 May;30(5):1231–1235. [PubMed] [Google Scholar]
  29. Zimmerman T. S., Müller-Eberhard H. J. Blood coagulation initiation by a complement-mediated pathway. J Exp Med. 1971 Dec 1;134(6):1601–1607. doi: 10.1084/jem.134.6.1601. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES